A comprehensive view of Perrigo PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Raymond James: Perrigo's acquisition of HRA Pharma may be overlooked by investors, as HRA is expected to file application for OTC birth control pill by end-2022; in light of Roe v. Wade ruling, potential annual sales of HRA pill could hit US$100M-US$200M

Fitch affirms Perrigo's issuer default rating at BB+ after financing HRA Phrama acquisition, which adds blister care, women's health, scar care to product portfolio; Perrigo should generate at least US$40M in annual cost synergies during next three years

Plackers releases EcoChoice Compostable Dental Flossers, designed to be 100% biodegradable, decompose in home composter after 26 weeks; flossers made of Danimer Scientific's PHA, a biopolymer derived from Canola oil, natural silk floss and coconut coating

OTC pharmaceutical company Perrigo completes acquisition of Hera SAS for €1.8B; acquisition projected to expand Perrigo’s geographic reach, drive category penetration, deliver new product innovations

Perrigo announces planned retirement of Ray Silcock, EVP and CFO, July 15, 2022; company has initiated a search for a successor

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count